Work from Yeudall et al. performed in lung cancer cells identified CXCL5, CXCL8, and CXCL12 as transcriptional activation targets of mutated p53 via NF-κB, regardless of TNF-α stimulation [74]. This evidence concerns the gene TP53 and lung carcinoma.